The KCNK1 Knockout HAP1 Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal knockout cell population targeting the KCNK1 gene in the HAP1 human near-haploid cell line. This knockout model is generated through CRISPR/Cas9-mediated gene disruption, eliminating functional expression of the TWIK-1 (tandem of P domains in a weak inward rectifying K+ channel) potassium leak channel encoded by KCNK1. The polyclonal nature preserves genetic diversity within the edited pool, enabling robust assessment of loss-of-function phenotypes without the confounding effects of clonal selection. This product is designed for rigorous functional genomics and drug discovery applications requiring a physiologically relevant knockout background.
HAP1 is a near-haploid human cell line derived from a male patient with chronic myeloid leukemia (CML). Its stable haploid karyotype facilitates straightforward genetic manipulation and unambiguous genotype-phenotype correlation, making it a preferred model for knockout screens and mechanistic studies. As a blood cancer cell line, HAP1 retains key oncogenic signaling pathways and offers a simplified genetic landscape for dissecting gene function in malignancies, particularly those involving dysregulated ion homeostasis and cellular excitability.
KCNK1 encodes TWIK-1, a two-pore domain K+ leak channel that mediates background potassium conductance, thereby setting the resting membrane potential and regulating cellular excitability. TWIK-1 activity is modulated by upstream signals including G??q-coupled receptors, protein kinase A (PKA), diacylglycerol, and acidic pH. Its downstream effects extend to voltage-gated Na+ and Ca2+ channels, cell cycle regulators, and apoptosis mediators. Interactions with beta-COP, 14-3-3 proteins, ARF6, and the SUMO conjugation machinery link TWIK-1 to membrane trafficking, signal integration, and post-translational modification. Through these connections, KCNK1 influences MAPK and PI3K signaling pathways, impacting proliferation, survival, and volume regulation.
In the context of HAP1 leukemic cells, KCNK1 knockout provides a platform to investigate how loss of background potassium leak currents alters cancer cell behavior. TWIK-1 dysfunction is implicated in pathological states such as cancer, epilepsy, and cardiovascular diseases. The near-haploid background of HAP1 simplifies genetic studies and allows for direct observation of ion homeostasis disruption, changes in cell proliferation, apoptosis induction, and altered volume regulation. This model is particularly relevant for exploring how KCNK1-mediated membrane potential control interfaces with oncogenic signaling and stress responses.
This polyclonal KCNK1 knockout cell population is well-suited for a broad range of experimental assays, including patch-clamp electrophysiology, membrane potential detection via FLIPR, cell proliferation assays (BrdU, MTT), annexin V flow cytometry for apoptosis, ion flux measurements, and gene/protein expression analysis by RT-qPCR and western blotting. Typical research applications encompass functional genomics, drug screening targeting ion channels, cancer biology investigations, and studies of cellular volume regulation. For further information, please contact Ascent Research.
